Calendar of Events
M Mon
T Tue
W Wed
T Thu
F Fri
S Sat
S Sun
0 events,
0 events,
0 events,
0 events,
2 events,
CFAR: EHR Data-Driven Research and the Promise of Advanced Analytics
CFAR: EHR Data-Driven Research and the Promise of Advanced Analytics
Emily Pfaff, PhD, MS, Associate Professor in the Division of Endocrinology and Metabolism, specializes in clinical informatics. She is co-director of Informatics and Data Science with the TraCS Institute. This is a hybrid event, held in Bioinformatics 2127 and Zoom.
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
1 event,
Friday Conference: T32 HIV-STI Fellows
Friday Conference: T32 HIV-STI Fellows
The T32 STI/HIV Training Program trains fellows to conduct STI/HIV research, fostering skills in interdisciplinary research. The following will present their work: Teresa (Tess) Filipowicz, MPH; Alexander Commanday, MD; and Lauren Graybill, PhD, MS (virtually)
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
1 event,
Friday Conference: T32 Pathogenesis Fellows
Friday Conference: T32 Pathogenesis Fellows
The T32 Pathogenesis Training Program trains the next generation of researchers in microbiology, preparing them to address critical needs in infectious diseases. The following will present their work: Farhang Aghakhanian, PhD, MSc; Nathaniel Chapman, PhD; Thomas Holowka, MD, PhD; and Zachary Popkin-Hall, PhD.
0 events,
0 events,
0 events,
0 events,
0 events,
1 event,
PAUSE Seminar: Anaerobic Antibiotics, the Gut Microbiome and CAR T Outcomes
PAUSE Seminar: Anaerobic Antibiotics, the Gut Microbiome and CAR T Outcomes
Tessa Andermann, PhD, Assistant Professor of Medicine, studies infectious diseases of immunocompromised patients. Dr. Andermann’s research focus on how intestinal microbiome-host interactions impact infectious complications and other outcomes in patients with hematologic malignancies. Her goal is to develop microbiome-targeted therapies for the prevention and treatment of infectious diseases in these and other immunocompromised patient populations.